Cannabis Stocks Rise Following DEA Rescheduling Announcement
The U.S. Department of Justice rescheduled marijuana from Schedule I to III, potentially removing the IRS's 280E restrictions on cannabis companies' deductions. This has led to a surge in shares for major players like Trulieve and Curaleaf.
Topics: 280E repeal cannabis Curaleaf Trulieve